Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
154.06
-1.86 (-1.19%)
At close: Aug 28, 2026, 4:00 PM EDT
154.94
+0.88 (0.57%)
After-hours: Aug 28, 2026, 7:45 PM EDT
Neurocrine Biosciences Market Cap
Neurocrine Biosciences has a market cap or net worth of $15.66 billion as of August 28, 2026. Its market cap has increased by 14.31% in one year.
Market Cap
15.66B
Enterprise Value
15.73B
1-Year Change
14.31%
Ranking
Category
Stock Price
$154.06
ChartMarket Cap Chart
Since December 1, 1998, Neurocrine Biosciences's market cap has increased from $124.10M to $15.66B, an increase of 12,518.91%. That is a compound annual growth rate of 19.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 15.66B | 10.74% |
| Dec 31, 2025 | 14.14B | 2.32% |
| Dec 31, 2024 | 13.82B | 6.76% |
| Dec 29, 2023 | 12.95B | 12.74% |
| Dec 30, 2022 | 11.48B | 42.11% |
| Dec 31, 2021 | 8.08B | -9.78% |
| Dec 31, 2020 | 8.96B | -9.54% |
| Dec 31, 2019 | 9.90B | 52.87% |
| Dec 31, 2018 | 6.48B | -5.69% |
| Dec 29, 2017 | 6.87B | 104.24% |
| Dec 30, 2016 | 3.36B | -31.05% |
| Dec 31, 2015 | 4.88B | 187.17% |
| Dec 31, 2014 | 1.70B | 169.95% |
| Dec 31, 2013 | 629.00M | 26.66% |
| Dec 31, 2012 | 496.60M | 5.73% |
| Dec 30, 2011 | 469.70M | 12.07% |
| Dec 31, 2010 | 419.10M | 293.15% |
| Dec 31, 2009 | 106.60M | -13.68% |
| Dec 31, 2008 | 123.50M | -28.41% |
| Dec 31, 2007 | 172.50M | -56.31% |
| Dec 29, 2006 | 394.80M | -82.96% |
| Dec 30, 2005 | 2.32B | 28.86% |
| Dec 31, 2004 | 1.80B | -6.54% |
| Dec 31, 2003 | 1.92B | 37.67% |
| Dec 31, 2002 | 1.40B | 3.88% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zoetis | 31.96B |
| United Therapeutics | 22.11B |
| Viatris | 18.77B |
| Elanco Animal Health | 12.05B |
| Dr. Reddy's Laboratories | 10.27B |
| Alkermes | 7.95B |
| Hims & Hers Health | 6.73B |
| Lantheus Holdings | 6.58B |